Noteworthy, CAD-T2DM-derived CD34+ HSPCs displayed, despite in vitro culture and differentiation, a “glucophenotype” characterized by myelopoietic and inflammatory features that were irrespective of the presence of CAD and of lipidemic profile of the patients [56]. This evidence concerns the gene CD34 and type 2 diabetes mellitus.